Page 1 of Clinical Trials for ( Immunology AND Angiogenesis inhibition ), 73 Total Matches
- 1Enrolling by invitation
- 2CompletedLast Updated: February 9, 2012Condition(s): Prostatic Neoplasms
- 3Active, not recruitingLast Updated: August 26, 2011Condition(s): Multiple Myeloma
- 4WithdrawnLast Updated: December 4, 2006Condition(s): Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage I Pancreatic Cancer; Stage II Pancreatic Cancer; Stage III Pancreatic Cancer
- 5RecruitingLast Updated: April 25, 2012Condition(s): Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
- 6CompletedLast Updated: November 9, 2010Condition(s): Diabetic Retinopathy
- 7CompletedLast Updated: July 1, 2010Condition(s): Multiple Myeloma
- 8Active, not recruitingLast Updated: August 26, 2011Condition(s): Multiple Myeloma
- 9TerminatedLast Updated: March 14, 2011Condition(s): Kidney Cancer
- 10CompletedLast Updated: July 1, 2010Condition(s): Waldenstrom Macroglobulinemia
- 11CompletedLast Updated: July 1, 2010Condition(s): Leukemia
- 12RecruitingLast Updated: October 19, 2011Condition(s): Medulloblastoma
- 13CompletedLast Updated: July 1, 2010Condition(s): Multiple Myeloma
- 14CompletedLast Updated: March 30, 2012Condition(s): Neoplasms
- 15RecruitingLast Updated: February 7, 2012Condition(s): Colorectal Cancer
- 16WithdrawnLast Updated: December 4, 2006Condition(s): Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
- 17WithdrawnLast Updated: January 11, 2007Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 18CompletedLast Updated: March 30, 2012Condition(s): Kidney Cancer
- 19Active, not recruitingLast Updated: January 15, 2011Condition(s): Breast Cancer
- 20CompletedLast Updated: October 13, 2011Condition(s): Hepatocellular Carcinoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Immunology%2C+Angiogenesis+inhibition
